Targacept/GSK’s Nicotinic Receptor Modulator Fails Phase II Pain Study
This article was originally published in The Pink Sheet Daily
Executive Summary
Experimental pain killer performed no better than placebo, failing a proof-of-concept study for post-operative pain.